Chord Energy Corporation (CHRD) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$6.52	$6.44	-1.2%	—	$2.2B	—
Q1 26	$1.56	$2.05	+31.4%	—	$1.7B	—
Q4 25	$1.24	$1.28	+3.2%	—	$1.2B	—
Q3 25	$2.29	$2.35	+2.6%	—	$1.3B	—
Q2 25	$1.88	$1.79	-4.8%	—	$1.2B	—
Q1 25	$3.54	$4.04	+14.1%	—	$1.2B	—
Q4 24	$2.81	$3.49	+24.2%	—	$1.5B	—
Q3 24	$3.78	$3.41	-9.8%	—	$1.5B	—
Q2 24	$5.09	$4.69	-7.9%	—	$1.3B	—
Q1 24	$4.76	$5.1	+7.1%	—	$1.1B	—
Q4 23	$5.11	$5.25	+2.7%	—	$964.7M	—
Q3 23	$4.97	$5.04	+1.4%	—	$1.1B	—
Q2 23	$3.83	$3.65	-4.7%	—	$912.1M	—
Q1 23	$4.29	$6.13	+42.9%	—	$896.5M	—
Q4 22	$6.09	$5.28	-13.3%	—	$1B	—
Q3 22	$8.78	$7.2	-18.0%	—	$1.2B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.74	—	—	$4.9B	—
FY24	—	$16.3	—	—	$5.3B	—
FY23	—	$24.6	—	—	$3.9B	—
FY22	—	$60.9	—	—	$3.6B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	—	—	$2.3B	$1.9B	$1.1B	$1.6B	$3.6B	$3.9B	$5.3B	$4.9B
YoY change	—	—	—	-16.8%	-43.9%	+45.8%	+130.8%	+6.85%	+34.8%	-7.12%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	—	—	2.3B	1.9B	1.1B	1.6B	3.6B	3.9B	5.3B	4.9B
Cost of revenue	—	—	1.7B	1.9B	843.3M	909.8M	1.9B	2.5B	3.9B	4B
Gross profit	—	—	623.4M	80.2M	240M	670.1M	1.8B	1.4B	1.3B	866.4M
Gross margin	—	—	26.8%	4.15%	22.2%	42.4%	49.1%	36.9%	24.9%	17.8%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	—	—	121.3M	128.6M	159.5M	80.7M	209.3M	126.3M	205.6M	126.3M
Operating expenses	—	—	148.8M	135.3M	162.3M	83.5M	211.5M	161.6M	222.6M	677.7M
Operating income	—	—	474.7M	-55.1M	77.8M	586.6M	1.6B	1.3B	1.1B	188.7M
Operating margin	—	—	20.4%	-2.85%	7.18%	37.1%	43.3%	32.7%	20.6%	3.87%
Non-operating income, net	—	—	-340.9M	-136.5M	-3.9B	-367.8M	-166M	91.7M	86M	134.9M
Pretax income	—	—	-25.3M	-350.9M	-4B	188M	1.4B	1.3B	1.1B	243.5M
Income tax	—	—	-5.8M	-32.7M	-266.4M	-973K	-46.9M	315.2M	263.8M	199M
Net income	—	—	-19.5M	-128.2M	-3.8B	319.6M	1.9B	1B	848.6M	44.5M
Net margin	—	—	-0.84%	-6.64%	-348.1%	20.2%	50.9%	26.3%	16.2%	0.91%
EBITDA	—	—	1.1B	724.8M	377.9M	743.9M	2B	1.9B	2.2B	1.7B
EPS	-1.32	0.53	-1.77	-6.42	-184.6	16.1	60.9	24.6	16.3	0.74
Diluted EPS	-1.32	0.52	-1.77	-6.42	-184.6	15.5	57.5	23.5	16	0.74

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	1.1B	964.7M	1.1B	1.3B	1.5B	1.5B	1.2B	1.2B	1.3B	1.2B	1.7B	2.2B
Cost of revenue	743.8M	587.2M	781.8M	903.6M	1.1B	1.1B	842.2M	1B	1.1B	1B	1.3B	1.5B
Gross profit	379.6M	377.5M	303.5M	357.1M	335.3M	309.7M	372.8M	171.8M	195.1M	126.7M	372.9M	635.3M
Gross margin	33.8%	39.1%	28%	28.3%	23.1%	21.3%	30.7%	14.6%	14.9%	10.8%	22.4%	29.2%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	26.1M	25.5M	25.7M	82.1M	52.1M	45.7M	38.4M	32.5M	21.9M	33.5M	37.5M	29.9M
Operating expenses	27.7M	27.6M	31.9M	83.6M	59.4M	47.8M	40.4M	32.5M	23.9M	39M	40.1M	29.9M
Operating income	351.8M	349.9M	271.6M	273.5M	275.9M	261.9M	332.5M	139.2M	171.2M	87.8M	332.9M	605.4M
Operating margin	31.3%	36.3%	25%	21.7%	19%	18%	27.4%	11.8%	13%	7.51%	20%	27.9%
Non-operating income, net	-69.1M	46.2M	-7.2M	30M	48.2M	14.9M	-23.7M	-456.1M	17.9M	54.9M	-212M	108.5M
Pretax income	274.8M	389.7M	256.9M	291.4M	304.9M	259.3M	293M	-335.7M	170.3M	115.9M	94.3M	687.3M
Income tax	65.7M	88M	57.5M	78M	79.6M	48.7M	73.2M	54.2M	40.2M	31.5M	-14.3M	162.1M
Net income	209.1M	301.6M	199.4M	213.4M	225.3M	210.6M	219.8M	-389.9M	130.1M	84.4M	108.6M	525.2M
Net margin	18.6%	31.3%	18.4%	16.9%	15.5%	14.5%	18.1%	-33%	9.92%	7.22%	6.52%	24.2%
EBITDA	527.3M	518M	459.7M	511.4M	634.5M	641.5M	676.9M	520.3M	543.6M	462.1M	746.3M	1B
EPS	5.01	—	4.79	4.36	3.63	3.45	3.67	-6.71	2.26	1.48	1.9	9.3
Diluted EPS	4.77	—	4.65	4.25	3.59	3.43	3.66	-6.77	2.26	1.48	1.9	9.28

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	—	—	65.2M	740.9M	2.5B	—	—	—	—	7.4B
Enterprise value	—	—	—	2.8B	1B	2.8B	—	—	—	—	8.3B
Shares outstanding	183.6M	235M	20M	20M	20M	19.8M	30.5M	41.5M	51.8M	57.8M	57.8M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	—	—	7.8	—	—	—	—	9.21
P/S	—	—	—	0.03	0.68	1.58	—	—	—	—	1.25
P/B	—	—	—	0.02	0.73	2.04	—	—	—	—	0.9
EV/EBITDA	—	—	—	3.88	2.68	3.71	—	—	—	—	3.13
EV/Sales	—	—	—	1.46	0.93	1.75	—	—	—	—	1.4
Earnings yield	—	—	—	—	—	12.8%	—	—	—	—	10.9%
FCF yield	—	—	—	36.3%	-5.89%	28.1%	—	—	—	—	13%
PEG	—	—	—	—	—	—	—	—	—	—	-0.04

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	—	—	26.8%	4.15%	22.2%	42.4%	49.1%	36.9%	24.9%	17.8%	29.2%
Operating margin	—	—	20.4%	-2.85%	7.18%	37.1%	43.3%	32.7%	20.6%	3.87%	34.7%
Net margin	—	—	-0.84%	-6.64%	-348.1%	20.2%	50.9%	26.3%	16.2%	0.91%	14.2%
ROE	—	—	—	-3.34%	-372.3%	26.2%	39.7%	20.2%	9.75%	0.55%	10.3%
ROA	—	—	—	-1.71%	-174.6%	10.6%	28%	14.8%	6.51%	0.34%	5.37%
ROIC	—	—	—	-0.84%	6.06%	39.5%	34.5%	18.4%	8.51%	0.36%	10.1%
Return on tangible assets	—	—	—	-1.71%	-195.3%	10.6%	28%	14.8%	7.09%	0.34%	6.18%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	—	—	—	0.73	0.8	1.32	1.09	1.22	0.94	1.06	1.22
Quick ratio	—	—	—	0.67	0.73	1.29	1.05	1.16	0.88	0.98	1.15
Debt / equity	—	—	—	0.72	0.28	0.36	0.1	0.11	0.12	0.2	0.18
Debt / assets	—	—	—	0.37	0.13	0.14	0.07	0.08	0.08	0.12	0.12
Net debt / EBITDA	—	—	—	3.79	0.72	0.36	-0.05	0.11	0.45	0.86	0.37
Interest coverage	—	—	0.83	-1.32	-21.9	7.1	48.1	47.8	20.7	4.04	11.8
Effective tax rate	—	—	0%	0%	0%	0%	0%	23.5%	23.7%	81.7%	20.5%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	—	—	116.1	96.6	54.2	79.8	119.6	93.9	101.4	84.4	104.9
EPS (basic)	-1.32	0.53	-1.77	-6.42	-184.6	16.1	60.9	24.6	16.3	0.74	0.74
EPS (diluted)	-1.32	0.52	-1.77	-6.42	-184.6	15.5	57.5	23.5	16	0.74	14.8
Book value per share	—	—	—	191.9	50.7	61.7	153.5	122.4	168	139.8	151.4
FCF per share	—	—	-7.77	1.18	-2.18	35.4	45.7	22	17.7	12	21
Cash per share	—	—	—	1	0.54	8.7	19.4	7.66	0.71	3.28	11.2
Capex per share	—	—	16.5	2.12	0.76	18.9	—	—	—	23.3	24.7

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	—	14.2%	2.19%	1.4%	23.6%	—	—	—	27.6%	22.1%
Capex / operating cash flow	—	—	52.3%	5.86%	-0.35%	104.5%	—	—	—	66.1%	54.1%
Payout ratio	—	—	—	0%	—	35%	35.3%	48.9%	62.4%	714.7%	35.1%
Dividend yield	—	—	—	0%	—	4.49%	—	—	—	—	3.85%

Yield

3.85%

trailing twelve months

Frequency

Quarterly

Last dividend

$1.30

ex-dividend Aug 20, 2026

Payout ratio

35%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 20, 2026	$1.30
May 20, 2026	$1.30
Mar 12, 2026	$1.30
Nov 19, 2025	$1.30
Aug 21, 2025	$1.30
May 21, 2025	$1.30
Mar 11, 2025	$1.30
Nov 27, 2024	$1.44

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$1.1B	$964.7M	$1.1B	$1.3B	$1.5B	$1.5B	$1.2B	$1.2B	$1.3B	$1.2B	$1.7B	$2.2B
YoY change	-5.51%	-5.01%	+21.1%	+38.2%	+29.1%	+50.8%	+12%	-6.36%	-9.54%	-19.6%	+37.1%	+84%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	20M	10.7M	172.1M	593.2M	318M	37M	189.5M
Receivables	276.6M	159.9M	309.8M	661.1M	749.4M	1B	894.3M
Inventory	35.3M	21.6M	29M	54.4M	72.6M	94.3M	115.7M
Total current assets	437.4M	271.6M	1.6B	1.5B	1.4B	1.6B	1.5B
Property, plant & equipment	7B	852.3M	-59.6M	-384.9M	-984.2M	-2B	-3.5B
Goodwill & intangibles	0	228.4M	—	—	—	1.1B	0
Total assets	7.5B	2.2B	3B	6.6B	6.9B	13B	13.1B
Accounts payable	17.9M	2.6M	2.1M	29.1M	34.5M	68.8M	41.8M
Short-term debt	40.3M	20.3M	37.4M	83.7M	120.9M	186.5M	136M
Total current liabilities	602.9M	341.2M	1.2B	1.4B	1.2B	1.7B	1.5B
Long-term debt	2.7B	261.6M	399.2M	407.5M	414.6M	857.8M	1.5B
Total liabilities	3.7B	1.1B	1.8B	2B	1.8B	4.3B	5B
Shareholders' equity	3.8B	1B	1.2B	4.7B	5.1B	8.7B	8.1B
Total debt	2.8B	281.9M	436.6M	491.1M	535.4M	1B	1.6B
Net debt	2.7B	271.2M	264.5M	-102M	217.4M	1B	1.4B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	265M	318M	296.4M	197.4M	52M	37M	35.8M	40.5M	629.2M	189.5M	225.8M	611.6M
Receivables	850.1M	749.4M	795.3M	977.2M	1B	1B	1B	1B	945.6M	894.3M	1.1B	1.1B
Inventory	64.9M	72.6M	78.1M	79.9M	77.5M	94.3M	103.8M	102M	108.5M	115.7M	100.2M	121.4M
Total current assets	1.4B	1.4B	1.4B	1.6B	1.6B	1.6B	1.6B	1.5B	2.1B	1.5B	1.7B	2.2B
Property, plant & equipment	-816.9M	-984.2M	-1.1B	-1.3B	-1.7B	-2B	-2.4B	-2.8B	-3.1B	-3.5B	-3.9B	-4.3B
Goodwill & intangibles	—	—	—	1.1B	1.1B	1.1B	1.1B	0	0	0	—	—
Total assets	6.9B	6.9B	7B	13.1B	13B	13B	13.1B	12.5B	13.1B	13.1B	13.2B	13.7B
Accounts payable	2.6M	34.5M	39.5M	38.2M	68.4M	68.8M	89.9M	74M	61.6M	41.8M	90.8M	151.9M
Short-term debt	138.1M	120.9M	123.1M	231.6M	184.4M	186.5M	158.6M	163.6M	146M	136M	125.4M	134.3M
Total current liabilities	1.4B	1.2B	1.2B	1.7B	1.7B	1.7B	1.8B	1.6B	1.5B	1.5B	1.7B	1.8B
Long-term debt	417.6M	414.6M	412.3M	1B	888.2M	857.8M	809.4M	927.1M	1.5B	1.5B	1.5B	1.5B
Total liabilities	2B	1.8B	2B	4.3B	4.3B	4.3B	4.4B	4.5B	5B	5B	5.2B	5.4B
Shareholders' equity	4.9B	5.1B	5.1B	8.8B	8.8B	8.7B	8.6B	8.1B	8.1B	8.1B	8B	8.4B
Total debt	555.8M	535.4M	535.5M	1.2B	1.1B	1B	968M	1.1B	1.6B	1.6B	1.6B	1.6B
Net debt	290.8M	217.4M	239.1M	1B	1B	1B	932.3M	1.1B	1B	1.4B	1.4B	1B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	-19.5M	-90.6M	-3.8B	355.3M	1.9B	1B	848.6M	44.5M
Depreciation & amortization	636.3M	787.2M	307.2M	158.3M	369.7M	598.6M	1.1B	1.5B
Stock-based compensation	29.3M	33.6M	31.6M	15.5M	61.3M	46.1M	23M	25.7M
Change in working capital	-37.6M	-2M	151.4M	-183.9M	81.7M	-168.9M	-75M	161M
Operating cash flow	631.6M	722.8M	-4.3B	357.2M	2.4B	1.8B	2.1B	2B
Capital expenditure	330.4M	42.4M	15.2M	373.2M	—	—	—	-1.3B
Investing cash flow	-251M	40.5M	15.2M	-555.7M	-195.1M	-266.6M	-569.3M	-1.9B
Dividends paid	—	0	—	-111.9M	-654.7M	-500.3M	-529.9M	-317.8M
Share repurchases	-6.8M	-4.9M	-2.8M	-100M	-151.9M	-239.3M	-444.2M	-364.9M
Financing cash flow	1.3B	-56.8M	-281.2M	-347.2M	-827.9M	-755.9M	-660.3M	-82.5M
Net change in cash	1.6B	706.5M	-4.6B	-545.8M	1.4B	773.1M	897.8M	84.3M
Free cash flow	-155.4M	23.6M	-43.6M	701.3M	1.4B	914.2M	918.2M	692.7M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	209.1M	301.6M	199.4M	213.4M	225.3M	210.6M	219.8M	-389.9M	130.1M	84.4M	108.6M	525.2M
Depreciation & amortization	160.3M	167.4M	168.9M	227.9M	360.2M	350.7M	349.8M	377M	374.9M	368.4M	384.2M	409.2M
Stock-based compensation	10.1M	8.8M	4.8M	5.4M	5.9M	6.9M	6.9M	6.1M	6.5M	6.2M	8M	8.8M
Change in working capital	-233.8M	51.7M	-38.7M	299K	-16.9M	-19.7M	-28.3M	30.4M	50.3M	108.6M	-252M	22.3M
Operating cash flow	181.6M	647.9M	363.9M	495.4M	649.8M	618.3M	568.2M	419.8M	559M	405M	507.5M	1.1B
Capital expenditure	—	—	—	—	—	—	—	-395.5M	-340.4M	-303.1M	-351.3M	-404.2M
Investing cash flow	-21.7M	8.4M	15M	-631.4M	-5.8M	36.6M	14.3M	-390M	-392.9M	-782.3M	-326.8M	-407.9M
Dividends paid	-56.9M	-105.7M	-152.4M	-129.3M	-156M	-92.2M	-86.5M	-82.4M	-74.6M	-74.3M	-74.2M	-73.5M
Share repurchases	-111.3M	-82.2M	-32M	-61.7M	-146.1M	-204.4M	-215.2M	-58.9M	-83.8M	-7M	-67.7M	-149.9M
Financing cash flow	-168.9M	-189M	-230.8M	372.2M	-474.4M	-327.2M	-365.8M	-29.6M	402.3M	-89.5M	-146.8M	-224.2M
Net change in cash	-9M	467.4M	148.1M	236.2M	169.6M	327.7M	216.7M	290K	568.4M	-466.8M	33.8M	484M
Free cash flow	164.7M	280.2M	184.5M	144.3M	324.6M	264.8M	348M	24.3M	218.5M	101.9M	156.2M	711.9M

Chord Energy Corporation Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement